Durand P-Y, Benevent D, Issad B, Chanliau J, Kessler M
Peritoneal dialysis in 15 cirrhotic patients with chronic renal
failure: long term study
17th Annual CAPD Conference
Perit Dial Int Suppl 1
(Feb) 17:S59 1997
Patients with end stage liver disease (ESLD) and ascites represent a
particularly challenging subset of the ESRD population. These French
investigators studied 15 patients with ascites on CAPD with alcoholic,
post-hepatitis, toxic, or amyloid associated cirrhosis of at least
Child's Class B. The overall peritonitis rate (1 episode per 19 patient
months) was better than that observed for more stable patients in other
developed countries including the USA (1 episode per 12-18 patient
months). Also noted was an increase in ultrafiltration and
transperitoneal solute clearance (creatinine D/P 0.75 and glucose
peritoneal desaturation 0.31). While only 7 patients were alive after a
mean of 4.6 years on therapy (range 1.2 - 14 years), none of the deaths
were due to complications of CAPD.
Comment: These observations support the adequacy and safety of
peritoneal dialysis in patients with ESLD and ascites. The remarkably
low peritonitis rate noted by these investigators deserves further
elucidation.
(Sri Narsipur, MD, SUNY-HSC at Syracuse, NY)
To go back use the BACK button on your browser.
Otherwise click on the desired link to this article below:
17th Annual CAPD Conference
CRF by organ system :
GI/Liver, Hepatitis